CMTM4 and neoplasm: Furthermore, MDSCs showed increased M1-like anti-tumor functional phenotype and reduced M2-like pro-tumor phenotype in CMTM4 KO tumor-bearing mice (Fig. 6E; Appendix Fig. S10B–D).